Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Glutamine PET Imaging of Colorectal Cancer

Trial Profile

Glutamine PET Imaging of Colorectal Cancer

Recruiting
Phase of Trial: Phase 0

Latest Information Update: 19 Dec 2018

At a glance

  • Drugs BAY 949392 (Primary) ; Glutamine
  • Indications Colorectal cancer
  • Focus Diagnostic use; Pharmacokinetics
  • Most Recent Events

    • 10 Dec 2018 Primary endpoints changed also trial focus changed to Pharmacokinetics (PK) and Diagnostic Use (DU).
    • 31 Aug 2018 Biomarkers information updated
    • 18 Oct 2017 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top